CervoMed (CRVO) Net Margin (2009 - 2025)
CervoMed's Net Margin came in at -92680.38% for Q4 2025, down 92370.21 percentage points from -310.17% a year earlier and down 90285.04 percentage points from the prior quarter.
Powered by 
Analysis
CervoMed (CRVO) Net Margin (2009 - 2025) Analysis & Trends
For FY2025, CervoMed's Net Margin was -673.06%, down 505.77 percentage points from FY2024.
- Going back by year, Net Margin was -167.29% in FY2024 (-136.89 pp) and -30.40% in FY2023.
- The Q4 2025 figure represents the lowest quarterly Net Margin in data going back to Q3 2011.
- Year-over-year, Net Margin has declined for six consecutive quarters, with an average year-over-year change of -11912.40 percentage points over the last eight quarters.
- The fastest year-over-year change in Net Margin over five years came in Q2 2024 (a gain of 12.44 percentage points), and the weakest in Q4 2025 (a drop of 92370.21 percentage points).
- Business Quant data shows CRVO's Net Margin at -2395.34% (Q3 2025), -356.05% (Q2 2025) and -255.23% (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 26.44% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.83% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 24.24% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 28.01% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 20.69% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 37.28% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 29.27% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 19.55% |
| 10 | CervoMed | 20.73 Mn | -57.60 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -92,680.38% |
| Sep 30, 2025 | -2,395.34% |
| Jun 30, 2025 | -356.05% |
| Mar 31, 2025 | -255.23% |
| Dec 31, 2024 | -310.17% |
| Sep 30, 2024 | -245.06% |
| Jun 30, 2024 | -70.44% |
| Mar 31, 2024 | -107.12% |
| Dec 31, 2023 | -94.85% |
| Sep 30, 2023 | -172.15% |
| Jun 30, 2023 | -82.88% |
| Mar 31, 2023 | -37.95% |
| Jun 30, 2022 | -7,567.09% |
| Mar 31, 2022 | -16,277.61% |
| Sep 30, 2021 | -24,057.18% |
| Jun 30, 2021 | -6,840.68% |
| Mar 31, 2021 | -11,490.30% |
| Dec 31, 2020 | -16,241.08% |
| Sep 30, 2020 | -15,185.62% |
| Jun 30, 2020 | -19,587.08% |
API Access
CervoMed Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=CRVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "CRVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=CRVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();